- Home
- SVCC vs CMPX Comparison
SVCC vs CMPX Comparison
Compare SVCC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVCC
- CMPX
- Stock Information
- Founded
- SVCC 2024
- CMPX 2014
- Country
- SVCC United States
- CMPX United States
- Employees
- SVCC N/A
- CMPX N/A
- Industry
- SVCC
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SVCC
- CMPX Health Care
- Exchange
- SVCC Nasdaq
- CMPX Nasdaq
- Market Cap
- SVCC 218.3M
- CMPX 229.5M
- IPO Year
- SVCC 2025
- CMPX N/A
- Fundamental
- Price
- SVCC $10.13
- CMPX $2.10
- Analyst Decision
- SVCC
- CMPX Strong Buy
- Analyst Count
- SVCC 0
- CMPX 8
- Target Price
- SVCC N/A
- CMPX $13.13
- AVG Volume (30 Days)
- SVCC 22.2K
- CMPX 804.2K
- Earning Date
- SVCC 01-01-0001
- CMPX 05-08-2025
- Dividend Yield
- SVCC N/A
- CMPX N/A
- EPS Growth
- SVCC N/A
- CMPX N/A
- EPS
- SVCC N/A
- CMPX N/A
- Revenue
- SVCC N/A
- CMPX $850,000.00
- Revenue This Year
- SVCC N/A
- CMPX N/A
- Revenue Next Year
- SVCC N/A
- CMPX N/A
- P/E Ratio
- SVCC N/A
- CMPX N/A
- Revenue Growth
- SVCC N/A
- CMPX N/A
- 52 Week Low
- SVCC $9.95
- CMPX $0.77
- 52 Week High
- SVCC $10.14
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- SVCC N/A
- CMPX 56.95
- Support Level
- SVCC N/A
- CMPX $2.02
- Resistance Level
- SVCC N/A
- CMPX $2.23
- Average True Range (ATR)
- SVCC 0.00
- CMPX 0.12
- MACD
- SVCC 0.00
- CMPX 0.02
- Stochastic Oscillator
- SVCC 0.00
- CMPX 66.67
About SVCC Stellar V Capital Corp. Class A Ordinary Shares
Stellar V Capital Corp is a blank check company.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.